Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    Advanced Search
    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Canadian Federal Government
        • Canadian Municipal Government
        • Canadian Provincial Government
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Advanced Search
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • IR
    • All Products
    • Become a Client
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • General Enquiries
    • Media
    • Worldwide Offices
    • Hamburger menu
    • Cision Canada
    • Send a Release
    • FR
      • Phone

      • 877-269-7890 from 8 AM - 10 PM ET

      • ALL CONTACT INFO
      • Contact Cision

        877-269-7890
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • 3 News in Focus
      • 5 Business
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • IR
      • All Products
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media
      • Worldwide Offices
      • General Enquiries
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business) Business
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Grown Rogue Reports Fourth Quarter and Annual 2024 Results


      News provided by

      Grown Rogue International Inc.

      Mar 31, 2025, 21:01 ET

      Share this article

      Share this article


      MEDFORD, Ore., March 31, 2025 /CNW/ - Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a craft cannabis company born from the amazing terroir of Oregon's Rogue Valley, is pleased to report its fourth quarter and full year results ended December 31, 2024. The Company changed its fiscal year-end from October to December during 2024, affecting year-over-year comparison periods, including making year-over-year quarterly comparisons less relevant. All financial information is provided in U.S. dollars unless otherwise indicated. 

      2024 Operational and Financial Highlights:

      • Revenue of $27.0M compared to $23.4M in the year ended October 31, 2023, an increase of 16%
      • Adjusted EBITDA of $9.7M compared to $7.6M in the year ended October 31, 2023, an increase of 27%
      • Adjusted EBITDA margin of 35.8% compared to 32.7% in the year ended October 31, 2023
      • Grown Rogue Received Licensing Approval in New Jersey and Closed Option 1 to Acquire 44% of ABCO Garden State, LLC ("ABCO"), with agreements in place to own up to 70%, pending regulatory approval
      • Commenced sales of Grown Rogue flower and pre-rolls in New Jersey in December and, as of mid-March, are selling into approximately half of the 205 dispensaries in the state
      • Increased ownership of Michigan operations from 60% to 80%
      • Convertible lenders voluntarily converted $3.1M of outstanding convertible debentures not due until 2027
      • Announced the termination of the advisory agreement with Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.)
      • Subsequent to year-end, the Company appointed Andrew Marchington as Chief Financial Officer and Josh Rosen as Chief Strategy Officer
      • Subsequent to year-end Nile, the Company's affiliated dispensary located in West New York, New Jersey, opened in February 2025, with its grand opening event planned for Saturday, March 29
      • Subsequent to year-end, the Company closed a US$7.0M credit facility at ~9% interest

      2024 Fourth Quarter Financial Highlights:

      • Revenue of $5.7M and adjusted EBITDA of $2.6M
      • Adjusted EBITDA margin of 46.9%

      Management Commentary  

      "This was another productive year for Grown Rogue with growth in both revenue and aEBITDA showing the continued execution by our team in competitive markets against a backdrop of price compression that was most pronounced in the back half of the year. Our core markets of Oregon and Michigan performed well in 2024 with strong market share increases in both markets. Our sales in OR and MI grew 10% and 13%, respectively, while state sales in OR were flat and MI were up 8%, indicating continued strong demand for our flower and pre-roll products. Our state-level EBITDA margins in 2024 were affected by lower pricing, particularly in Oregon, but we remain relentlessly focused on offsetting this competitive environment with strong cost controls, operational efficiencies and yield improvements. We continue to see pricing pressure early in 2025, most significantly in Michigan and we're optimistic that we'll see this pressure subside as we move through the year. Fortunately, our strong execution and resulting margin profile makes us resilient.," said Obie Strickler, CEO of Grown Rogue.

      "I'm so proud of everyone on the Grown Rogue team for both maintaining the focus on continuous improvement in our existing operations and simultaneously delivering against an aggressive go-to-market timeline in New Jersey. Augmenting our team as we grow, while retaining and growing our core talent, is the linchpin of our success. I believe we're doing a remarkable job of executing against the things we control. Our near-term focus remains on continuous operational improvements, construction of phase two at the New Jersey facility, the buildout of our facility in Illinois, and our ongoing measured pursuit of new markets. Our recently announced credit facility supports these growth initiatives on attractive terms by industry standards. We continue to believe that high-quality, low-cost cannabis cultivation, that delights consumers, is a protectable moat when done at the proper scale," continued Mr. Strickler.

      "I want to personally thank all our customers, the entire Grown Rogue team, and our supportive partners and shareholders for each doing their part to help Grown Rogue achieve our goal of becoming a nationally recognized craft flower company in the U.S. I look forward to providing future updates, most notably as we actively increase our penetration in the New Jersey market."

      Oregon Market Highlights ($USD Millions) 

      Oregon

      FY 2024

       FY 2023*

      +/- %

      Revenue

      12.1

      11.0

      +10 %

      aEBITDA

      3.6

      4.4

      -18 %

      aEBITDA Margin % 

      30.0 %

      40.1 %

      -1010 bps

      * FY 2023 data is from November 2022 to October 2023

      Michigan Market Highlights ($USD Millions) 

      Michigan

      FY 2024

      FY 2023*

      +/- %

      Revenue

      12.9

      11.4

      +13 %

      aEBITDA

      5.8

      5.3

      +8 %

      aEBITDA Margin %

      44.5 %

      46.7 %

       -220 bps

      * FY 2023 data is from November 2022 to October 2023

      Michigan operations are through Golden Harvests, LLC.

      Financial Statements and aEBITDA reconciliation

        Consolidated Statements of Financial Position

      December 31, 2024

      December 31, 2023

      October 31, 2023


      $

      $

      $

      ASSETS




      Current assets




      Cash and cash equivalents (Note 18)

      4,682,221

      6,804,579

      8,858,247

      Accounts receivable (Note 18)

      1,596,912

      1,642,990

      2,109,424

      Biological assets (Note 3)

      1,554,622

      1,723,342

      1,566,822

      Inventory (Note 4)

      4,769,776

      5,021,290

      4,494,257

      Prepaid expenses and other assets

      864,009

      420,336

      392,787

      Notes receivable (Note 6.3)

      7,189,635

      -

      -

      Total current assets

      20,657,175

      15,612,537

      17,421,537

      Warrants asset (Note 13.2)

      4,855,795

      8,820,897

      8,753,266

      Other Investments (Note 6.1 and 6.2)

      1,810,363

      -

      -

      Notes receivable (Notes 6.3)

      2,613,969

      2,449,122

      1,430,526

      Property and equipment (Note 8)

      11,870,220

      1,761,382

      1,361,366

      Intangible assets and goodwill (Note 9)

      1,257,668

      725,668

      725,668

      Deferred tax asset (Note 20)

      250,620

      246,294

      470,358

      TOTAL ASSETS

      43,315,810

      29,615,900

      30,162,721

      LIABILITIES




      Current liabilities




      Accounts payable and accrued liabilities

      2,107,619

      1,358,962

      2,359,750

      Current portion of lease liabilities (Note 7)

      736,453

      925,976

      824,271

      Current portion of long-term debt (Note 10)

      227,679

      780,358

      1,285,604

      Current portion of convertible debentures (Note 11)

      1,945,226

      -

      -

      Current portion of business acquisition consideration payable (Note 5)

      536,881

      360,000

      360,000

      Derivative liability (Notes 11.1.1, 11.2 and 11.2.1)

      12,504,175

      7,471,519

      7,808,500

      Income tax payable (Note 20)

      1,907,177

      873,388

      366,056

      Total current liabilities

      19,965,210

      11,770,203

      13,004,181

      Lease liabilities (Note 7)

      4,475,490

      1,972,082

      2,094,412

      Long-term debt (Note 10)

      1,001,681

      82,346

      102,913

      Business acquisition consideration payable (Note 5)

      1,693,540

      -

      -

      Convertible debentures

      -

      2,459,924

      2,412,762

      Other non-current liabilities (Note 20)

      269,883

      -

      -

      TOTAL LIABILITIES

      27,405,804

      16,284,555

      17,614,268

      EQUITY




      Share capital (Note 12)

      38,499,491

      24,593,422

      24,593,422

      Contributed surplus (Notes 13 and 14)

      9,025,541

      8,186,297

      8,081,938

      Accumulated other comprehensive loss

      (125,930)

      (108,069)

      (114,175)

      Accumulated deficit

      (32,847,334)

      (20,353,629)

      (20,996,449)

      Equity attributable to shareholders                                       

      14,551,768

      12,318,021

      11,564,736

      Non-controlling interests (Note 23)

      1,358,238

      1,013,324

      983,717

      TOTAL EQUITY

      15,910,006

      13,331,345

      12,548,453

      TOTAL LIABILITIES AND EQUITY

      43,315,810

      29,615,900

      30,162,721

      Consolidated Statements of Comprehensive Income (Loss)

       

      Year ended

      Two months ended

      Year ended


      December 31, 2024

      December 31, 2023

      October 31, 2023


      $

      $

      $

      Revenue




      Product sales (Note 2.1.6.1)

      25,029,634

      3,542,037

      22,424,169

      Service revenue (Note 2.1.6.2)

      1,987,631

      96,050

      929,016

      Total revenue

      27,017,265

      3,638,087

      23,353,185

      Cost of goods sold




      Cost of finished cannabis inventory sold

      (12,827,041)

      (1,404,323)

      (11,155,676)

      Costs of service revenue

      (206,669)

      (89,210)

      (308,641)

      Gross profit, excluding fair value items

      13,937,355

      2,144,554

      11,888,868

      Realized fair value loss amounts in inventory sold

      (3,358,862)

      (460,647)

      (2,573,151)

      Unrealized fair value gain amounts on growth of biological assets

      2,816,943

      686,867

      3,355,797

      Gross profit

      13,441,636

      2,370,774

      12,671,514

      Expenses




      Amortization of property and equipment

      939,727

      186,415

      578,641

      General and administrative (Note 19)

      10,075,360

      1,437,353

      6,465,877

      Share-based compensation

      1,306,607

      104,359

      346,113

      Total expenses

      12,321,694

      1,728,127

      7,390,631

      Income from operations

      1,119,942

      642,647

      5,280,883

      Other income and (expense)




      Interest expense

      (379,161)

      (69,164)

      (370,616)

      Accretion expense

      (2,042,556)

      (216,493)

      (1,026,732)

      Other income (expense)

      1,938,713

      49,678

      441,487

      Gain on extinguishment on note receivable

      156,165

      -

      -

      Unrealized gain (loss) on derivative liability

      (12,768,905)

      336,981

      (4,563,498)

      Unrealized gain on warrants asset

      3,094,413

      400,016

      129,113

      Loss on equity investment in associate

      (169,637)

      -

      -

      Gain (loss) on disposal of property and equipment

      50,057

      (87,699)

      (182,025)

      Total other income (expense), net

      (10,120,911)

      413,319

      (5,572,271)

      Income (loss) before taxes

      (9,000,969)

      1,055,966

      (291,388)

      Income tax (Note 20)

      (1,695,825)

      (383,539)

      (370,932)

      Net income (loss)

      (10,696,794)

      672,427

      (662,320)

      Other comprehensive income (items that may be
      subsequently reclassified to profit & loss)




      Currency translation gain (loss)

      (17,861)

      6,106

      (4,562)

      Total comprehensive income (loss)

      (10,714,655)

      678,533

      (666,882)

      Gain (loss) per share attributable to owners of the parent – basic

      (0.05)

      0.00

      (0.00)

      Weighted average shares outstanding – basic

      209,441,725

      182,005,886

      172,708,792

      Gain (loss) per share attributable to owners of the parent – diluted

      0.01

      0.00

      0.00

      Weighted average shares outstanding – diluted

      237,428,458

      214,046,728

      172,708,792

      Net income (loss) for the period attributable to:




      Non-controlling interest

      606,848

      29,607

      (129,279)

      Shareholders

      (11,303,642)

      642,820

      (533,041)

      Net income (loss)

      (10,696,794)

      672,427

      (662,320)

      Comprehensive income (loss) for the period attributable to:




      Non-controlling interest

      606,848

      29,607

      (129,279)

      Shareholders

      (11,321,503)

      648,926

      (537,603)

      Total comprehensive income (loss)

      (10,714,655)

      678,533

      (666,882)

      Consolidated Statements of Cash Flows

       

      Year ended

      Two months ended

      Year ended


      December 31, 2024

      December 31, 2023

      October 31, 2023


      $

      $

      $

      Operating activities




      Net income (loss)

      (10,696,794)

      672,427

      (662,320)

      Adjustments for non-cash items in net income (loss):




      Depreciation of property and equipment

      939,727

      186,415

      578,641

      Amortization of property and equipment included in costs of inventory sold

      1,980,597

      209,985

      1,757,672

      Unrealized fair value gain amounts on growth of biological assets

      (2,816,943)

      (686,867)

      (3,355,797)

      Realized fair value loss amounts in inventory sold

      3,358,862

      460,647

      2,573,151

      Deferred income taxes

      (4,326)

      224,064

      (470,358)

      Share-based compensation

      1,306,607

      104,359

      344,593

      Accretion expense

      2,042,556

      216,493

      1,026,732

      Loss on equity investment in associate

      169,637

      -

      -

      Gain on extinguishment on note receivable

      (156,165)

      -

      -

      (Gain) Loss on disposal of property and equipment

      (50,057)

      87,699

      182,025

      Unrealized (gain) loss on fair value of derivative liability

      12,768,905

      (336,981)

      4,563,498

      Unrealized gain on warrants asset

      (3,094,414)

      (400,016)

      (129,113)

      Currency translation gain (loss)

      (17,861)

      6,106

      (2,210)


      5,730,331

      744,331

      6,406,514

      Changes in non-cash working capital (Note 15)

      1,394,111

      (513,222)

      (677,163)

      Net cash provided by operating activities

      7,124,442

      231,109

      5,729,351





      Investing activities




      Purchase of property and equipment and intangibles

      (1,739,014)

      (126,690)

      (1,456,782)

      Acquisition of Canopy Management and Golden Harvests

      (801,436)

      -

      -

      Dividend issued from Golden Harvests, LLC to minority owner

      (530,000)

      -

      -

      Cash advances and loans made to other parties

      (7,898,136)

      (1,018,596)

      (1,430,526)

      Repayment of notes receivable principal and interest

      484,160



      Equity investment in ABCO Garden State LLC

      (1,980,000)

      -

      -

      Repayment of bridge note

      266,417

      -

      -

      Net cash used in investing activities

      (12,198,009)

      (1,145,286)

      (2,887,308)





      Financing activities




      Proceeds from convertible debentures

      -

      -

      8,000,000

      Proceeds from exercise of warrants

      4,657,460

      -

      -

      Proceeds from exercise of stock options

      359,958

      -

      -

      Proceeds from sales of membership units

      787,500

      -

      -

      Payment of debt and equity issuance costs

      (126,914)

      -

      -

      Repayment of long-term debt

      (1,230,093)

      (568,166)

      (1,631,830)

      Repayment of convertible debentures

      (521,953)

      (126,978)

      (261,006)

      Payments of lease principal

      (974,749)

      (444,347)

      (1,673,344)

      Net cash provided by (used in) financing activities

      2,951,209

      (1,139,491)

      4,433,820





      Change in cash and cash equivalents

      (2,122,358)

      (2,053,668)

      7,275,863

      Cash and cash equivalents, beginning

      6,804,579

      8,858,247

      1,582,384

      Cash and cash equivalents, ending

      4,682,221

      6,804,579

      8,858,247


                                         Year ended

       December 31

                                         Two months
      ended
      December 31

      Year ended October 31

      Adjusted EBITDA Reconciliation

      2024 ($)

      2023 ($)

      2023 ($)

      Net income (loss), as reported

      (10,696,794)

      672,427

      (662,320)

      Add back realized fair value amounts included in inventory sold

      3,358,862

      460,647

      2,573,151

      Deduct unrealized fair value gain on growth of biological assets

      (2,816,943)

      (686,867)

      (3,355,797)

      Add back amortization of property and equipment included in cost of sales

      1,980,598

      209,985

      1,757,672


      (8,174,277)

      656,192

      312,706

      Add back interest and interest accretion expense, as reported

      2,421,717

      285,657

      1,397,348

      Add back amortization of property and equipment, as reported

      939,727

      186,415

      578,641

      Add back share-based compensation

      1,306,607

      104,359

      346,113

      Deduct unrealized gain/add back unrealized loss on derivative liability, as reported

      12,768,905

      (336,981)

      4,563,498

      Deduct gain / add back loss on disposal of property plant and equipment

      (50,057)

      87,699

      -

      Deduct unrealized gain on warrants asset, as reported

      (3,094,413)

      (400,016)

      (129,113)

      Deduct gain on extinguishment on note receivable

      (156,165)



      Add back income tax expense, as reported

      1,695,825

      383,539

      370,932

      EBITDA

      7,657,869

      966,864

      7,440,125

      Compliance costs 1

      -

      -

      83,747

      One time compensation payments

      264,336

      -

      -

      Additional compliance costs associated with year end change

      79,091

      -

      -

      Costs associated with acquisition of Golden Harvests 2

      603,000

      20,000

      110,000

      New production location startup costs 3

      887,897

      -

      -

      Non recurring legal and transaction costs

      187,342

      -

      -

      Adjusted EBITDA

      9,679,535

      986,864

      7,633,872

      1Costs for professional services pertaining to prior periods as a result of efforts to bring the Company's disclosures current with the Securities & Exchange Commission. The Company's required disclosures were brought current, and over-the-counter trading resumed in the United States.

      2 Costs associated with the Company's acquisition of the Michigan assets.

      3 During the year ended December 31, 2024, we incurred 887,897 in pre-opening labor costs associated with the investment in New Jersey.

      Segmented Adjusted EBITDA







        Oregon

        Michigan

      Services 

        Corporate

        Consolidated

      Revenue

      12,093,606

      12,936,028

      1,258,131

      729,500

      27,017,265

      Costs of revenue

      (7,125,199)

      (5,701,841)

      (206,670)

      -

      (13,033,710)

      Gross profit

      4,968,407

      7,234,187

      1,005,261

      729,500

      13,983,555

      Net fair value ("FV") adjustments

      210,468

      (752,387)

      -

      -

      (541,919)

      Gross profit

      5,178,875

      6,481,800

      1,005,261

      729,500

      13,441,636

      Operating expenses:






      General and administration

      2,603,427

      2,762,657

      -

      4,709,276

      10,075,360

      Depreciation and amortization

      115,851

      641,120

      -

      182,756

      939,727

      Share based compensation

      -

      -

      -

      1,306,607

      1,306,607

      Other income and expense:






      Interest and accretion

      (241,572)

      (73,361)

      -

      (2,106,784)

      (2,421,717)

      Loss on disposal or property and equipment

      5,280

      44,777

      -

      -

      50,057

      Gain on extinguishment on note receivable

      -

      -

      -

      156,165

      156,165

      Unrealized (loss) gain on derivative liability

      -

      -

      -

      (12,768,905)

      (12,768,905)

      Unrealized (loss) gain on warrants asset

      -

      -

      -

      3,094,413

      3,094,413

      Other income and expense

      2,878

      238,848

      800,000

      896,987

      1,938,713

      Net income (loss) before tax

      2,226,183

      3,288,287

      1,851,461

      (16,366,900)

      (9,000,969)

      Tax

      -

      -

      -

      1,695,825

      1,695,825

      Net income (loss) after tax

      2,226,183

      3,288,287

      1,851,461

      (18,062,725)

      (10,696,794)

      Net FV adjustments

      (210,468)

      752,387

      -

      -

      541,919

      Amortization of property and equipment included in cost of sales

      1,254,370

      726,228

      -

      -

      1,980,598

      Amortization of property and equipment

      115,851

      641,120

      -

      182,756

      939,727

      Share-based compensation

      -

      -

      -

      1,306,607

      1,306,607

      Gain on extinguishment on note receivable

      -

      -

      -

      (156,165)

      (156,165)

      Unrealized derivative liability

      -

      -

      -

      12,768,905

      12,768,905

      Loss on disposal of property plant and equipment

      (5,280)

      (44,777)

      -

      -

      (50,057)

      Unrealized warrants asset

      -

      -

      -

      (3,094,413)

      (3,094,413)

      Interest and accretion

      241,572

      73,361

      -

      2,106,784

      2,421,717

      Income tax

      -

      -

      -

      1,695,825

      1,695,825

      EBITDA before one-time adjustments

      3,622,228

      5,436,606

      1,851,461

      (3,252,426)

      7,657,869

      Add back to EBITDA:






      One time compensation payments

      -

      -

      -

      264,336

      264,336

      Additional compliance costs

      -

      -

      -

      79,091

      79,091

      Eliminated management fees

      -

      -

      -

      -

      46,200

      Costs associated with acquisition of Golden Harvests

      -

      323,000

      -

      280,000

      603,000

      New production location startup costs

      -

      -

      -

      887,897

      887,897

      Non recurring legal and transaction costs

      -

      -

      -

      187,342

      187,342

      Adjusted EBITDA

      3,622,228

      5,759,606

      1,851,461

      (1,553,760)

      9,679,535

      NOTES: 

      1. The Company's "aEBITDA," or "Adjusted EBITDA," is a non-IFRS measure used by management that does not have any prescribed meaning by IFRS and that may not be comparable to similar measures presented by other companies. The Company defines "EBITDA" as the Company's net income or loss for a period, as reported, before interest, taxes, depreciation and amortization, and is further adjusted to remove transaction costs, stock-based compensation expense, accretion expense, gain (loss) on derecognition of derivative liabilities, the effects of fair-value accounting for biological assets and inventory, as well as other non-cash items and items not representative of operational performance as reported in net income (loss). Adjusted EBITDA is defined as EBITDA adjusted for the impact of various significant or unusual transactions. The Company believes that this is a useful metric to evaluate its operating performance.  

      NON-IFRS FINANCIAL MEASURES
      EBITDA and aEBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The Company has also provided unaudited pro-forma financial information, which assumes that closed and pending mergers and acquisitions in 2021 are included in the Company's financial results as of the beginning of the quarterly and annual periods in 2021. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-IFRS financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the IFRS financial measures presented herein. Accordingly, the following information provides reconciliations of the supplemental non-IFRS financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with IFRS. 

      About Grown Rogue

      Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a craft cannabis company operating in Oregon, Michigan, New Jersey and Illinois, focused on delighting customers with premium flower and flower-derived products at fair prices. The Company's roots are in Southern Oregon, where it has proven its capabilities in the highly competitive and discerning Oregon market. The Company's passion for quality product and value, combined with a disciplined approach to growth, prioritizes profitability and return on capital without sacrificing quality. The Company's strategy is to pursue capital efficient methods to expand into new markets, bringing craft-quality product at fair prices to more consumers. The Company also continues to make modest investments to improve outdoor craft cultivation capabilities in preparation for eventual interstate commerce. For more information, visit www.grownrogue.com.

      FORWARD-LOOKING STATEMENTS

      This press release contains statements which constitute "forward‐looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward‐ looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward‐looking information is not based on historical facts but instead reflect the Company's management's expectations, estimates or projections concerning the business of the Company's future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward‐looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward‐looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Company's public disclosure documents filed on Sedar.

      Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward‐looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward‐looking information except as otherwise required by applicable law.

      The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business are disclosed in the Company's Listing Statement filed on its issuer profile on SEDAR+ at www.sedarplus.ca. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

      No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

      SOURCE Grown Rogue International Inc.

      For further information on Grown Rogue, please visit www.grownrogue.com or contact: Obie StricklerChief Executive Officer, [email protected]; Jakob Iotte, Vice President of Investor Relations, [email protected], (458) 226-2662

      Modal title

      Organization Profile

      Grown Rogue International Inc.

        Also from this source

      • Grown Rogue Reports Third Quarter 2026 Results

      • From Dwight to Dispensary Shelves: Grown Rogue Makes Its Illinois Debut

      • Grown Rogue Increases Ownership Stake to 70% in New Jersey Subsidiary, ABCO Garden State

      Contact PR Newswire

      • 866-245-2317
        from 7:30 AM - 6:30 PM ET
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • Investor Relations

      About

      • About PR Newswire
      • About Cision
      • Careers
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • Platform Login
      • Privacy Policy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      • Next Gen Communications Cloud
      • Cision Communications Cloud
      • my CNW
      877-269-7890
      from 8 AM - 10 PM ET
      • Terms of Use
      • Information Security Policy
      • Site Map
      • Cookie Settings
      • Accessibility Statement
      Copyright © 2026 CNW Group Ltd. All Rights Reserved. A Cision company.